Concepedia

Harry Kochat

HK

Statistics

Publications

6

Citations

90

H-Index

6

Active since

2009

Affiliations

BioNumerik (United States)(Current)

Zenobia Therapeutics (United States)

Harry Kochat is an author at BioNumerik (United States) specializing in molecular oncology, biochemistry, and chemotherapy.

Publications per year

2009–2024

6

Publications

6

Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of gamma-glutamyl transpeptidase

Frederick H. Hausheer, Dakshine Shanmugarajah, Betsy D. Leverett et al. · Cancer Chemotherapy and Pharmacology · 2009 · 21 citations

, , +9

Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N

F. H. Hausheer, Aulma R. Parker, Pavankumar Petluru et al. · Cancer Chemotherapy and Pharmacology · 2010 · 20 citations

, , +13

Analysis of BNP7787 thiol-disulfide exchange reactions in phosphate buffer and human plasma using microscale electrochemical high performance liquid chromatography

Dakshine Shanmugarajah, Daoyuan Ding, Quili Huang et al. · Journal of Chromatography B · 2009 · 16 citations

, , +12

Cysteine Specific Targeting of the Functionally Distinct Peroxiredoxin and Glutaredoxin Proteins by the Investigational Disulfide BNP7787

Aulma R. Parker, Pavankumar Petluru, V. Nienaber et al. · Molecules · 2015 · 11 citations · Full text

, , +16

Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787

Aulma R. Parker, Pavankumar Petluru, V. Nienaber et al. · OncoTargets and Therapy · 2015 · 11 citations · Full text

, , +14

1–5 of 6